Drug Profile
Research programme: diabetes nanoparticle therapeutics - MidaSol Therapeutics
Alternative Names: GLP-1 - MidaSol; GLP-1/insulin - MidaSol; Midaform™ GLP-1; Midaform™ insulin/GLP-1; PharmFilm®Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator MidaSol Therapeutics
- Class Glucagon-like peptides; Hormones; Insulins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in Spain (Buccal, Film)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in Switzerland (Buccal, Film)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA (Buccal, Film)